转基因小鼠的糖尿病是由于胰腺β细胞中I类基因相容性分子的过度表达导致的
J Allison1, I L Campbell, G Morahan
1Walter and Eliza Hall Institute of Medical Research, Royal Melbourne Hospital, Victoria, Australia.
Nature
|June 9, 1988
概括
转基因小鼠在胰腺β细胞中过度表达I类基因相容性基因,患上糖尿病. 这表明这些分子在疾病中扮演着直接的角色,独立于免疫细胞的参与.
科学领域:
- 免疫遗传学 免疫遗传学
- 内分泌学 在内分泌学.
- 分子生物学分子生物学
背景情况:
- 一类的基因相容性分子对于免疫反应至关重要.
- 鼠类胰岛素促进剂 (RIP) 驱动胰腺β细胞中的基因表达.
- 转基因模型对于研究活体中的基因功能至关重要.
研究的目的:
- 研究胰腺β细胞中过度表达的H-2Kb类I基因相容性基因的作用.
- 为了确定H-2Kb过度表达是否会导致转基因小鼠的糖尿病.
- 探索H-2Kb可能导致糖尿病的机制,特别是其潜在的非免疫作用.
主要方法:
- 转基因小鼠的生成与H-2Kb与老鼠胰岛素促进剂相关.
- 对转基因小鼠胰腺β细胞功能和形态学的分析.
- 在受影响小鼠的胰腺中评估免疫细胞透 (T细胞).
- 评估疾病发展 (胰岛素依赖性糖尿病) 在综基因和异基因上下文.
主要成果:
- 发现H-2Kb在生成的转基因小鼠的胰腺β细胞中过度表达.
- 转基因小鼠,无论转基因是否具有同基因或异基因状态,都会发展出胰岛素依赖型糖尿病.
- 在糖尿病转基因小鼠的胰腺中没有观察到可检测的T细胞透.
- 这表明转基因I类分子具有直接的致病作用.
结论:
- 在胰腺β细胞中过度表达H-2Kb可以直接导致胰岛素依赖糖尿病.
- 疾病机制似乎独立于T细胞介导的免疫反应.
- 转基因I类分子可能在糖尿病的发病过程中发挥直接的非免疫作用.
相关概念视频
Diabetes Mellitus: Overview and Type I Subtype
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Glucose Homeostasis: Pancreatic Islets and Insulin Secretion
The pancreatic islets comprising only 1%-2% of the volume are highly vascularized and innervated mini-organs. They contain five endocrine cell types, including β cells that secrete insulin, which is synthesized as a single polypeptide chain, preproinsulin, processed to proinsulin, and finally to insulin and C-peptide. This process is complex and regulated, involving the Golgi complex, the endoplasmic reticulum, and the secretory granules of the β cell.
Insulin and C-peptide are co-secreted in...
Insulin and C-peptide are co-secreted in...
Type I Diabetes I: Introduction
Type 1 diabetes mellitus is a chronic metabolic disorder characterized by an absolute deficiency of insulin resulting from the autoimmune destruction of pancreatic β-cells. Although it can occur at any age, it is most commonly diagnosed in childhood, adolescence, or early adulthood. The loss of insulin production impairs cellular glucose uptake, resulting in persistent hyperglycemia and necessitating lifelong insulin therapy.Autoimmune Destruction of β-CellsThe hallmark of type 1 diabetes is an...
Type I Diabetes II: Pathophysiology
Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...
Type II Diabetes I: Introduction
Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...
Type II Diabetes II: Pathophysiology
PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.


